NCT02723994 2026-03-11A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic LeukemiaIncyte CorporationPhase 2 Completed171 enrolled
NCT00186875 2017-07-28Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic LeukemiaSt. Jude Children's Research HospitalPhase 2 Completed47 enrolled 10 charts